ProgynyPGNY
PGNY
About: Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Employees: 680
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
179% more call options, than puts
Call options by funds: $8.57M | Put options by funds: $3.07M
2.06% more ownership
Funds ownership: 95.64% [Q3] → 97.7% (+2.06%) [Q4]
2% more capital invested
Capital invested by funds: $1.4B [Q3] → $1.44B (+$30.8M) [Q4]
7% less funds holding
Funds holding: 283 [Q3] → 262 (-21) [Q4]
20% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 96
25% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 72
67% less funds holding in top 10
Funds holding in top 10: 3 [Q3] → 1 (-2) [Q4]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$23
1%
upside
Avg. target
$25
11%
upside
High target
$28
23%
upside
3 analyst ratings
2 positive
67%
1 neutral
33%
0 negative
0%
BTIG David Larsen 43% 1-year accuracy 6 / 14 met price target | 23%upside $28 | Buy Upgraded | 31 Mar 2025 |
Canaccord Genuity Richard Close 29% 1-year accuracy 7 / 24 met price target | 1%upside $23 | Hold Maintained | 28 Feb 2025 |
B of A Securities Michael Cherny 71% 1-year accuracy 20 / 28 met price target | 9%upside $25 | Buy Maintained | 11 Feb 2025 |
Financial journalist opinion
Based on 5 articles about PGNY published over the past 30 days
Neutral
GlobeNewsWire
6 days ago
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building, will report its financial results for the quarterly period ended March 31, 2025, after the close of the market on Thursday, May 8, 2025.
Positive
Zacks Investment Research
1 week ago
Why Progyny (PGNY) is Poised to Beat Earnings Estimates Again
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Neutral
GlobeNewsWire
1 week ago
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer
The leadership additions support the company's continued ability to scale as it delivers the right care model for women's health and family building The leadership additions support the company's continued ability to scale as it delivers the right care model for women's health and family building
Neutral
GlobeNewsWire
2 weeks ago
Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week®
As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides a platform for the millions of individuals facing family building challenges As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides a platform for the millions of individuals facing family building challenges
Neutral
GlobeNewsWire
3 weeks ago
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, and The Broken Brown Egg, a nonprofit supporting BIPOC individuals and couples experiencing infertility, today announced the launch of their 2025 Awareness, Hope, and Activism (AHA) Grant, marking the fourth consecutive year of this family building partnership.
Neutral
GlobeNewsWire
1 month ago
Progyny Expands Maternal Health Support with Addition of Doula Services
Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes
Neutral
GlobeNewsWire
1 month ago
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation
Neutral
GlobeNewsWire
1 month ago
Progyny, Inc. to Participate in Upcoming Investor Conferences
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced it expects to participate in several upcoming investor conferences. Progyny executives will participate in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami, FL on Monday, March 10, 2025, at 11:20 a.m. Eastern Time. The executives will then be participating in meetings at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 11, 2025.
Positive
Schwab Network
1 month ago
PGNY CEO on "Well-Positioned" Sales Year & Expanding Footprint
Pete Anevski, CEO of Progyny (PGNY), discusses his company's latest earnings and how it's poised for a "well-positioned" year. He notes general healthcare headwinds for the women's health company, though he expects Progyny to find new clients and retain current customers.
Positive
The Motley Fool
2 months ago
Progyny Tops EPS Forecast, Eyes Growth
Progyny (PGNY -1.68%), a pioneer in fertility benefits management, released its earnings for the fourth quarter on Feb. 27. The standout points were its impressive revenue and adjusted earnings per share (EPS) results, both of which surpassed analysts' consensus predictions.
Charts implemented using Lightweight Charts™